GEODE CAPITAL MANAGEMENT, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$4,154,605
-23.1%
1,197,152
+3.1%
0.00%
-100.0%
Q2 2023$5,401,123
+10.7%
1,161,532
+10.0%
0.00%0.0%
Q1 2023$4,880,170
+59053.6%
1,056,314
+3.5%
0.00%0.0%
Q4 2022$8,250
-99.8%
1,021,079
+20.0%
0.00%0.0%
Q3 2022$4,721,000
+11.2%
850,747
+4.4%
0.00%0.0%
Q2 2022$4,245,000
-34.5%
814,789
+3.3%
0.00%0.0%
Q1 2022$6,483,000
-41.4%
788,796
+6.1%
0.00%0.0%
Q4 2021$11,065,000
-15.3%
743,679
+7.5%
0.00%
-50.0%
Q3 2021$13,071,000
+3.8%
691,976
+2.1%
0.00%0.0%
Q2 2021$12,598,000
-2.3%
677,706
+19.6%
0.00%0.0%
Q1 2021$12,896,000
+41.9%
566,649
+35.4%
0.00%0.0%
Q4 2020$9,085,000
+182.1%
418,519
+30.6%
0.00%
+100.0%
Q3 2020$3,220,000
+58.2%
320,484
+22.2%
0.00%
Q2 2020$2,035,000
+67.1%
262,322
+119.6%
0.00%
Q1 2020$1,218,000
-42.4%
119,453
-37.9%
0.00%
Q4 2019$2,116,000
+152.2%
192,432
+108.3%
0.00%
Q3 2019$839,000
-19.6%
92,375
+0.6%
0.00%
Q2 2019$1,044,000
+71.1%
91,793
+71.2%
0.00%
Q1 2019$610,000
-33.1%
53,620
-47.0%
0.00%
Q4 2018$912,000101,2020.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders